论文信息 - Results of a Phase II Study of 506U78 (Nelarabine) in Refractory Indolent B-Cell or Peripheral T-Cell Lymphoma. - 字舞流文

Results of a Phase II Study of 506U78 (Nelarabine) in Refractory Indolent B-Cell or Peripheral T-Cell Lymphoma.

A. Bleyer | F. Cabanillas | A. Sarris | L. Fayad | A. Goy | M. Thompson | F. Hagemeister | B. Pro | F. Samaniego